Abstract
Objectives This study aimed to investigate the relationship between Life’s Essential 8 (LE8) and the Atherogenic Index of Plasma (AIP).
Methods We conducted an analysis of data from 8,215 U.S. adults aged 20 years and older, utilizing the National Health and Nutrition Examination Survey data from 2007 to 2018. Based on LE8 scores, Cardiovascular Health (CVH) was stratified into three levels—low, moderate, and high—while AIP was categorized into four risk levels: extremely low (AIP<-0.3), low (−0.3≤AIP<0.1), medium (0.1≤AIP<0.24), and high (AIP≥0.24). Weighted ordinal logistic regression analysis was utilized to examine the association between CVH scores and AIP risk levels, adjusting for potential confounding variables.
Results A significant inverse correlation exists between CVH scores and AIP risk levels (OR=0.51, 95%CI: 0.49-0.54, P<0.001). Higher CVH scores were associated with lower AIP risk levels, while lower CVH scores corresponded to elevated AIP risk levels. Notably, improvements in specific CVH components—such as Body Mass Index and Blood Lipids—exhibited a strong relationship with reductions in AIP risk levels.
Conclusions Enhancing CVH is vital for effectively reducing AIP risk levels, thus underscoring the critical importance of health management strategies in the prevention of cardiovascular diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All study protocols have been approved by the National Center for Health Statistics Research Ethics Review Board, and written informed consent was obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Author Note: Longhui Xu, MSN in reading, Student, TEL.: 15080027402, E-mail: xulonghui1213{at}foxmail.com.
Kai-wen Ding, MSN, Supervisor nurse, TEL.: 13854139811, E-mail: dingkaiwen1991{at}163.com.
Guo-dong Yang, MSN in reading, Student, TEL.: 15653405374, E-mail: 849080484{at}qq.com.
Xiao-xuan Han, MSN in reading, Student, TEL.: 13869144866, E-mail: 13869144866{at}163.com.
Xiao Cong, MSN in reading, Student, TEL.: 15615392272, E-mail: congxiaowork{at}163.com.
Rong-hui Wang, MSN in reading, Student, TEL.:13854600933, E-mail:646592479{at}qq.com.
Xin-ru Liu, MSN in reading, Student, TEL.: 17865780595, E-mail: LXR17865780595{at}163.com.
Na Li, MSN in reading, Student, TEL.: 15863985427, E-mail: 1278092867{at}qq.com.
Data Availability
The data utilized in this study are derived from the National Health and Nutrition Examination Survey (NHANES): https://wwwn.cdc.gov/nchs/nhanes/Default.aspx, and the data used are publicly available. The corresponding author can be contacted for data.
